Title
Category
Credits
Event date
Cost
Addressing the Unpredictable Diagnostic Odyssey of Rare Disease
  • Disease management
  • Rare diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This presentation addresses the needs for improved access to care, new advances in rare-disease diagnosis, and treatments emerging with the rise of personalized precision medicine. New possibilities for collaboration among medicine, research and drug-development organizations are also discussed.
Personal Experience with Transplantation
  • Disease management
  • Transplantation
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This session examines the experiences and perspective of a transplant surgeon describing his personal journey as a transplant recipient.
The Diagnostic Odyssey for Individuals With Rare Diseases: Spotlight on the Patient, Achondroplasia (Podcast)
  • Disease management
  • Health equity
  • Rare diseases
  • 0.50 ACPE - Pharmacists
  • 0.50 ACPE - Pharmacy Technicians
  • 0.50 AMA - Physicians
  • 0.50 ANCC - Nurses
  • 0.50 APA - Psychologists
  • 0.50 Attendance - General Attendance
  • 0.50 CCMC - General - Case Managers
  • 0.50 ASWB - Social Workers
$0.00
This podcast will share insights and perspectives directly from Deborah Hecht, who is an individual with achondroplasia and a mother and grandmother of children with achondroplasia.
Managing Urinary Incontinence
  • Disease management
  • Older adults
  • Wellness
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 Attendance - General Attendance
$0.00
This activity will highlight the prevalence of UI; provide effective communication and shared decision-making techniques; and discuss how to assess, treat and provide follow-up care for UI including available resources to support care and management.
Unlocking Patient-reported Outcomes to Advance Quality, Experience and Decision Making
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This activity will explore the value of PRO measures in the health system and discuss methods of optimally integrating these measures. It will discuss strategies that the health care team and health system can use to interpret and apply PRO data to add value to current care delivery practices.
Diagnosis and Management of Ocular Symptoms Related to Concussion and Acquired Brain Injury
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will focus on the evaluation and management of oculomotor symptoms associated with acquired brain injuries (ABI) due to concussion, stroke and other causes. It will discuss the battery of tests that can establish the presence of oculomotor dysfunction and will cover available treatment options, including glasses, prism glasses, therapeutic eye drops and vision therapy. The importance of a team management approach through collaboration and referrals will be stressed. After this activity, eye doctors should be comfortable evaluating patients with a history of concussion or ABI.
Medically Necessary Contact Lenses
  • Disease management
  • Vision
  • 1.00 AMA - Physicians
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will provide a current update to participants’ comprehensive knowledge and understanding of various contact lens options for patients with common diagnoses requiring medically necessary contact lenses. This session will delve into the tool chest of contact lens solutions, including standard rigid gas permeable (RGP) lens designs, reverse geometry RGPs, hybrids and scleral lenses. Participants will explore the anatomy of contact lenses, specific designs and applications for conditions such as keratoconus and irregular corneas. The activity will also cover the advantages and considerations associated with each lens type, patient experiences and advancements in scleral lens designs.
Serious Illness Conversation
  • Behavioral health
  • Disease management
  • Palliative care and hospice
  • 2.00 AMA - Physicians
  • 2.00 ANCC - Nurses
  • 2.00 Attendance - General Attendance
$0.00
Activity descriptionConversations that provide patients who have serious and life-threatening illnesses with the opportunity to make informed choices reflecting their goals, values and care preferences are a critical part of their care. These discussions can help ensure that seriously ill patients receive care that is consistent with their wishes and provide guidance to enhance family well-being and improve the patient’s quality of life.
What’s New in Glaucoma Management?
  • Disease management
  • Vision
  • 1.00 AMA - Physicians
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will explore updated approaches to the management of glaucoma—the “silent thief of sight” that affects an estimated 3 million Americans. It will examine the latest evidence from recent studies on minimally invasive glaucoma surgery (MIGS) procedures and discuss comparative data on more invasive surgical techniques such as trabeculectomy and tube shunt surgery. Patient cases will be introduced to enhance participants’ understanding of the glaucoma treatment process. In addition, potential future innovations in glaucoma treatment will be discussed.
CRISPR-Based Therapies for Genetic Blood Disorders
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
Join this session to explore updates in genetic therapy for two prevalent hemaglobinopathies: sickle cell disease and beta thalassemia.

Pages